MORE►
UT Southwestern
DI People: Match Group, Island, UT Southwestern, BBG, and More Announce Leadership Moves
by David Seeley | May 6, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Techstars Physical Health Fort Worth Accelerator, Divurgent, IKS Health, Invitation Homes, Comerica, New Friends New Life, Lennox, Trademark Property, Golden State Foods, and Catapult Health.
by Kevin Cummings |
May 5, 2022
The Austin-based accelerator and investor plans to launch its Center for Health Innovation at Pegasus Park in Dallas by end of 2023. Its goal: connecting startups locally and across the state with each other, as well as other corporate and research players in the space.
“We're in the business of erasing boundaries in Texas—full stop,” President and Co-Founder Bryan Chambers told Dallas Innovates.
“We're in the business of erasing boundaries in Texas—full stop,” President and Co-Founder Bryan Chambers told Dallas Innovates.
MORE►
by Alex Edwards |
Nov 15, 2021
The $120 million Texas Instruments Biomedical Engineering and Sciences Building, supported by a gift from Dallas-based Texas Instruments, will focus on advancing transformational bioengineering research that can find solutions to unmet medical needs. It's set to open in 2023.
MORE►
by David Seeley |
Oct 25, 2021
The team is led by UTSW assistant professor Gary Hon, Ph.D., who developed Mosaic-seq, a gene engineering technique that helped lead to the grant award. UTSW will now become a research partner in a new $185M National Institutes of Health (NIH) initiative to build on findings of the Human Genome Project.
MORE►
The 2021 Cary Council grant recipients: Dr. Emily Adhikari, Dr. Owoicho Adogwa, and Dr. Samuel John [Photos: Cary Council]
Dallas ‘DocStars’ on COVID and Pregnancy, Cancer and Spine Studies, and Working Till Midnight on Early-Stage Research
by David Seeley | Oct 4, 2021
In partnership with the Southwestern Medical Foundation, the Cary Council awarded $50K grants to each of its three 2021 young "DocStars." On a recent "What's Up Doc?" virtual event, the young investigators spoke about how their research projects are going, what they hope to achieve—and why the seed grants are a catalyst for medical innovation.
MORE►
by David Seeley |
Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology.
OncoNano raised $50 million in Series B funding in June.
MORE►
by Michaela Markels |
Mar 3, 2021
Aaron Fritts, an interventional radiologist, and Gopi Shah, an otolaryngologist, co-founded BackTable in 2016 as a platform for the exchange of ideas, with the hope that it would propel healthcare into the future. Since, the startup has grown to include a podcast that has skyrocketed during the pandemic in terms of demand, scope of expertise, and impact.
MORE►
by Alexa Vickaryous |
Feb 24, 2021
The scientist's research indicates that exercise can reverse thin bones caused by old age, highlighting the importance of older patients staying active.
MORE►
Video screenshot: Blackstone LaunchPad
Blackstone Charitable Foundation Gives $5M to University of Texas Institutions to Expand Its Entrepreneurship Program
by Alex Edwards | Jan 26, 2021
The Blackstone LaunchPad entrepreneurship program, which has been at UT Dallas since 2016, is opening to a more diverse range of students by expanding to six new campuses. Locally, that includes UT Southwestern.
MORE►
by Alex Edwards |
Jan 13, 2021
The expanded alliance between Taysha and UTSW, which dates back to when Taysha emerged from stealth in April 2020, will support the discovery of novel gene therapy candidates and technologies in new disease areas.
MORE►
![This year’s winners from UT Southwestern —Olutoyosi “Toy” Ogunkua, M.D., Luis Sifuentes-Dominguez, M.D, and Chika Nwachukwu, M.D., Ph.D.—bring the total number grants awarded by the Council since its founding five years ago to nine. [Images via UTSW]](https://s24806.pcdn.co/wp-content/uploads/2021/01/UTSW-investigators-360x203.jpg)
by Alex Edwards |
Jan 11, 2021
Members raised nearly $100K in funding for the research awardees who will investigate new evidence-based pathways that can treat some of the world’s most intractable illnesses.
MORE►
by Quincy Preston |
Nov 17, 2020
People under age 50 are "more likely to be hospitalized, need a ventilator, and die from COVID-19 if they're severely obese," a new study says.
MORE►
[Image: Oleksandr Bushko/istockphoto]
UTSW Scientist: ‘We Need More Women Thinking Creatively in the Lab and Pushing Science Forward’
by Quincy Preston | Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
by Alex Edwards |
Oct 7, 2020
John Schoggins is one of 10 recipients for the National Institutes of Health's Pioneer Award. The forward-looking researcher is ahead of the curve, beginning the pursuit prior to the current pandemic.
MORE►
by Alex Edwards |
Sep 24, 2020
Using alternating magnetic fields in technology created by UTSW researchers, Solenic Medical aims to provide a better way to treat prosthetic joint infections than the current standard of care. Recently, the startup received an FDA designation of a Breakthrough Device.
MORE►
![R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]](https://s24806.pcdn.co/wp-content/uploads/2020/04/TayshaGene-Session-970-1-360x203.jpg)
by Quincy Preston and Alex Edwards |
Aug 5, 2020
Taysha Gene Therapies, which was been operating in stealth with UT Southwestern until this April, plans to use the financing to advance its initial cohort of lead programs into its clinic. By the end of 2021, Taysha expects to file four Investigational New Drug applications.
MORE►
